SCHEMBL7907147

SCHEMBL7907147

CS(=O)(=O)Nc1ccc(CCCC(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
GRIN1 Q05586 3/20 0.56
GRIN2B Q13224 3/20 0.56
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 1/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 1/20 0.56
HSD17B10 Q99714 1/20 0.54
HDAC1 Q13547 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC3 O15379 1/20 0.53
MAPK1 P28482 1/20 0.53
ADRA1A P35348 1/20 0.53
HDAC4 P56524 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL657740 0.90 ALDH1A1 (0.64) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL9764795 0.86 GRIN1 (0.58) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL10673 0.83 KDM4E (0.54) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL8763454 0.82 GRIN1 (0.65) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL8868256 0.81 KDM4E (0.61) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL5726108 0.81 HPGD (0.57) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL5737290 0.81 ALDH1A1 (0.56) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL2692935 0.80 HDAC1 (0.78) ALDH1A1SMN1; SMN2HDAC1HDAC8HDAC3
SCHEMBL10750177 0.80 ALDH1A1 (0.59) KDM4EGRIN1GRIN2BALDH1A1SMN1; SMN2
SCHEMBL9326251 0.80 ALDH1A1 (0.85) ALDH1A1LMNAHPGDHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104067122-B Based on acridine and the fluorescent dye of acridine derivatives 艾尔玛可科学(苏格兰)有限公司 2016-10-12 CN disclosed
CN-105492428-A Methods and compositions for treating beta-thalassemia and sickle cell disease ACADEMIA SINICA 2016-04-13 CN disclosed
US-6197975-B1 7-AZABICYCLO(2.2.1)HEPTANE-7-CARBONYL-SUBSTITUTED 2-PHENYLINDOLE DERIVATIVES; SEXUAL DISORDERS; ANTICARCINOGENIC AGENTS MERCK & CO. , INC. 2001-03-06 US disclosed
EP-0868178-A4 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO INC (US) 2000-03-29 EP disclosed
EP-0882040-A4 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO INC (US) 1999-02-10 EP disclosed
EP-0882040-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1998-12-09 EP disclosed
EP-0868178-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1998-10-07 EP disclosed
US-5756507-A TREATING SEX HORMONE RELATED DISORDERS MERCK & CO., INC. (US) 1998-05-26 US disclosed
EP-0781273-A1 4-(4-METHANESULFONAMIDOPHENYL)BUTYLAMINE DERIVATIVES WITH ANTIARRHYTHMIC ACTIVITY PHARMACIA & UPJOHN COMPANY (US) 1997-07-02 EP disclosed
WO-1997021707-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-06-19 WO disclosed
WO-1997021435-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-06-19 WO disclosed
WO-1996008471-A1 4-(4-METHANESULFONAMIDOPHENYL)BUTYLAMINE DERIVATIVES WITH ANTIARRHYTHMIC ACTIVITY PHARMACIA & UPJOHN COMPANY (US) 1996-03-21 WO disclosed
CN-1030409-A Indole derivatives and preparation method thereof GLAXO GROUP LTD (GB) 1989-01-18 CN disclosed
EP-0164865-A1 N-(Aminoalkylphenyl)sulfonamides their preparation and therapeutic use THE UPJOHN COMPANY (US) 1985-12-18 EP disclosed